Showing results (71-80 of 145) with videos related to
Sort By:
Pageof 15
Cancer Research|January 1, 1982
Surface marker identification of small cleaved follicular center cell lymphomas with a highly favorable prognosisR A Rudders, E T Ahl, R A Delellis, et al.Cancer|December 15, 1983
Adult non-Hodgkin's lymphoma. Correlation of cell surface marker phenotype with prognosis, the new working formulation, and the Rappaport and Lukes-Collins histomorphologic schemesR A Rudders, R A DeLellis, E T Ahl, et al.Cancer Treatment Reports|January 1, 1980
Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomasM J O'Connell, C B Begg, M N Silverstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1984
A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemiaC B Begg, P B McGlave, J M Bennett, et al.Cancer|April 15, 1994
Timed-sequential high-dose cyclophosphamide and vincristine in the treatment of multiple myelomaR E Lenhard, L A Kalish, M M Oken, et al.Urology|May 19, 2001
Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging StudyB A Mohr, H A Feldman, L A Kalish, et al.Urology|April 1, 1997
Planning controlled clinical trials. Prostatic cancerL Denis, B J Norlén, L Holmberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
High-dose ifosfamide with mesna uroprotection: a phase I studyA D Elias, J P Eder, T Shea, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2001
Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--MedicareD Schrag, S E Gelfand, P B Bach, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 2, 2001
Differences in difficulty adjudicating clinical events in patients with advanced HIV diseaseR Eisenbud, S F Assmann, L A Kalish, et al.Pageof 15